bergeel.com bergeel.com
Home -> About Us -> Add Your Link -> Privacy Policy -> Terms of Use -> Add Your Article
Search:   
Get Free Links
 

Health & Therapy

News & Events

Indoor Games

Recreation & Entertainment

Vehicles & Automotive

Outdoor & Sports

Banking & Finance

Realty & Property

Self Help

Software & Networking

Science & Research

Society & Communities

Food & Recipe

Relationship & Lifestyle

Home Family & Garden

Children

Business & Commerce

Careers & Employment

Shopping & Auction

Medicine & Treatment

Art & Culture

Travel & Accommodation

Law & Politics

Academics & Learning

 

Home –› Health & Therapy –› Weight Reduction
 

Pramlintide: A New Breakthrough to Deal with Obesity

 
Author: Clarence Carter
 

Pramlintide is a generic name for Symlin. It is an injectable drug which can facilitate you to reduce the sugar (glucose) levels in the blood. In essence, it is a synthetic hormone similar to amylin, which is created by the pancreas to manage blood glucose level. It is primarily beneficial for treating both Type 1 and Type 2 Diabetes. It also reflects a noteworthy result to condense appetite, thus acting as a weight loss drug. It received its FDA endorsement in March, 2005 adds to its dependability.

It works by retarding the making of glucose by the liver by restraining the action of glucagon, to control the manufacture of glucose by the liver. It basically retards the pace at which food constituting glucose is absorbed from the intestine. Symlin works in three distinct ways to smooth out the post-meal max out in blood sugar. Symlin firstly, slows down the momentum at which sugar exists the stomach. Secondly, Symlin reduces the amount of sugar that penetrates into the bloodstream from the liver. Lastly, it works indirectly to lessen the magnitude of sugar that enters the bloodstream by reducing appetite so that less food and, in turn a lesser amount of sugar is consumed.

Pramlintide is habitually used in consensus with other drugs to treat both Type1 and Type 2 Diabetes. Type1 refers to diabetics who necessitate insulin to harmonize their normal insulin fabrication. Such patients should start Pramlintide medication with 15'g up to 60'g, as tolerated. Type 2 refers to diabetics whose normal production of insulin lapses. Such patients should initiate with 60'g up to 120'g as necessitated.

This medication should be presented subcutaneously in the skin prior to the major meals. Discuss with your doctor if you are engaged in drugs, which can slow down the intestine or absorption of food. Expectant women and nursing mothers should seek advice from their gynecologist prior to Pramlintide treatment.

Most common Pramlintide side effects can be enumerated as:

? Hypoglycemia
? Vomiting
? Nausea
? Fatigue
? Abdominal pain
? Headache

In case you encounter these or any other side effects consult your doctor for immediate medical assistance. Kindly consult your doctor before embarking upon Pramlintide treatment

Unopened vials of Pramlintide should be refrigerated between 2-8'C (36-46'F). Opened vials of Pramlintide should either be refrigerated or kept at a room temperature (no greater than 77'F, 25'C) and used within a span of 28 days.

Symlin therapy should only be undertaken by patients with insulin-using type 2 or type 1 diabetics who have failed to achieve adequate glycemic control despite individualized insulin management and are receiving ongoing care under the guidance of a healthcare professional skilled in the use of insulin and supported by the services of diabetes educationalist.

 
 
 

Related Articles

 
How To Use Affirmations To Quit Smoking
 
Benefits You May Get From Cardio Training
 
The Sonoma Diet: Promoting a Lifestyle
 
5 Big Reasons to Consider Using Lutein Supplements
 
Hypnotist Kent Sayre on Confidence and Weight Loss
 
When Dieting Should You Weigh Yourself Every Day?
 
Here's How Love Could Be Your Anti- Aging Breakthrough
 
Self Hypnosis Cds - Tips for Choosing Hypnosis Cds
 
Woman's Issues: Premenstrual Syndrome (PMS)
 
Healthy Pregnancy: Pilates Helps Expecting Mothers
 
 
 
   Home -> Privacy Policy -> Terms of Use
All Rights Reserved © 2006 www.bergeel.com